Charlotte Damiano > Hogan Lovells (Paris) LLP > Paris, France > Lawyer Profile

Hogan Lovells (Paris) LLP
17 AVENUE MATIGNON
CS30027
75378 PARIS
France

Work Department

Global Regulatory - Health Law - Market Access, Pricing and Reimbursement

Position

Partner

Career

Charlotte Damiano is a partner in our Global Regulatory practice.

She assists Life Sciences players in issues relating to the market access of pharmaceutical products and medical devices. She is specialized in health technology assessment, early access programs, pricing and reimbursement and financial regulation (net price, safeguard clause, clawbacks) of health care products in France and abroad. She has extensive experience in market access, including in the context of disputes against the French health authorities. She assists clients in their negotiations with the health authorities (Ministry of health, central authorities, Economic committee of healthcare products notably) and has a strong network and knowledge of these authorities – before assisting them before courts.

She also represents pharmaceutical, biotechnology and medical devices companies in the context of tax and social security matters and litigations regarding all the financial aspects of the sale of healthcare products (contributions on sales, safeguard clause) .

Thus, Charlotte has a strong expertise in the life sciences sector.

Languages

English, French

Education

DEA in Economics and Business Law, Université Nice Sophia Antipolis School of Law

Lawyer Rankings

France > Industry focus: Healthcare and life sciences

(Leading individuals)

Charlotte Damiano – Hogan Lovells (Paris) LLP

Hogan Lovells (Paris) LLP houses a team which is known for its ‘broad and deep’ experience in contentious life sciences mandates, and its ‘very strong’ expertise in market access issues, data management and protection matters relating to clinical trials, and product liability claims. Notable clients include Eli Lilly, Merck & Co., and GE Healthcare. Practice head Mikael Salmela is noted for his longstanding expertise in handling regulatory assessments and M&A, in addition to product launches and supply transactions. Charlotte Damiano frequently acts for large pharma companies in both contentious and non-contentious matters involving pricing and reimbursement, negotiations with the French health authorities, and the financial regulations governing pharma products.